合成生物学产业发展与投融资战略研究

Strategic Research of the Development and Financing Status of Synthetic Biology Industry

合成生物学诞生于21世纪初,是多学科交叉的产物,发展迄今已将近20年。合成生物学几乎涉及生物科学研究的所有领域,结合工程学的模块化、抽象化思想,引入新的定量研究方法,提升了人们对生命系统的认知。不同于传统的基础学科或单一技术,合成生物学的复合性,极大地强化了人们对生物应用的能力,并散射到不同的应用版图。目前,合成生物学企业已撬动蓝海市场,在上游的使能技术开发,中游的技术平台建设,以及下游的医疗保健、农业食品和生物基化学品等领域取得了令人瞩目的成绩。该文从合成生物学产业的不同领域切入,结合业务类型、技术平台、公司融资状况,对目前合成生物学产业现状进行简要的介绍和分析,旨在为合成生物学技术、产业发展和投资方向提供参考。

As a multidisciplinary approach,synthetic biology has been developing for almost two decades.It involves almost all fields of biological research,combines the modules of engineering and abstract concepts,introduces new quantitative research methods,and improves people’s understanding of life system.Unlike traditional basic science or single technology,the complexity of synthetic biology significantly increases people’s capacity to apply biology and distribute it among different applications.At present,synthetic biology has made remarkable achievements in the development of enable technology,the establishment of synthetic biology platform,and the application in medical treatment,agriculture and food,and bio-based goods,promoting the development of the blue ocean market.Based on the concept of synthetic biology,numerous companies have emerged in many industrial areas recently.Some startups have thrived,and dominant companies have commercialized the technology through cost advantages.Based on this,the paper briefly introduces and analyzes the development of the synthetic biology industry,combining enterprise type,technology platform and financing conditions to provide reference for the development of technology,industry and investment in synthetic biology.